| 1 day | -16.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 21/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 14/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 03/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 29/08/2021 |
William Montour
BRD | Director/Board Member | - | 04/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/05/23 | Other | Director | 0 | 0% | ||
| 28/04/23 | Option | Director | 8,117 | 0.0189% | ||
| 28/04/23 | Tax | Chief Executive Officer | 3,184,422 | 7.4181% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -16.59% | -39.87% | - | - | 29.39M | ||
| +0.07% | +2.48% | +40.74% | -35.53% | 2.67B | ||
| -3.10% | -1.71% | -11.79% | +138.89% | 623M | ||
| 0.00% | -3.77% | -13.56% | -15.00% | 55.99M | ||
| Average | -4.90% | +0.64% | +5.13% | +29.45% | 1.12B | |
| Weighted average by Cap. | -0.66% | +2.16% | +30.07% | -2.79% |
Employees
-
Sector
Pharmaceuticals
















